Monday, April 28, 2014 11:01:06 PM
Hope this isn't old info but from NWBO's twitter page some quotes:
from 4/22/14: "NWBO will present on its DCVax-Direct trial at this year's #ASCO14 May30-June3. Abstract#TPS3133"
from 4/22/14:" ASCO14 will provide an opportunity for KOLs & clinicians to learn more about #DCVax-Direct"
from 4.22.14:"NWBio will present a poster & have an exhibit booth at ASCO14 MAy30-June3"
from 4/23/14:" NWBO to report on science & progress of #DCVax-Direct trial at #ASCO14, abstract #TPS3133, poster #189(a)"
from 4/23/14:" NWBO CEO states "our increased presence at #ASCO this year reflects the progress of our clinical programs"
from 4/23/14:" The focus on immune therapies like #DCVax at #ASCO14 is expected to be even greater this year"
from 4/24/14:" NWBio's #ASCO14 abstract # is TPS3133 & poster # is 189(a), learn more here"
from 13 hours ago:" We look forward to sharing information with KOLs & clinicians about #DCVax-Direct at ASCO14"
from 4/22/14: "NWBO will present on its DCVax-Direct trial at this year's #ASCO14 May30-June3. Abstract#TPS3133"
from 4/22/14:" ASCO14 will provide an opportunity for KOLs & clinicians to learn more about #DCVax-Direct"
from 4.22.14:"NWBio will present a poster & have an exhibit booth at ASCO14 MAy30-June3"
from 4/23/14:" NWBO to report on science & progress of #DCVax-Direct trial at #ASCO14, abstract #TPS3133, poster #189(a)"
from 4/23/14:" NWBO CEO states "our increased presence at #ASCO this year reflects the progress of our clinical programs"
from 4/23/14:" The focus on immune therapies like #DCVax at #ASCO14 is expected to be even greater this year"
from 4/24/14:" NWBio's #ASCO14 abstract # is TPS3133 & poster # is 189(a), learn more here"
from 13 hours ago:" We look forward to sharing information with KOLs & clinicians about #DCVax-Direct at ASCO14"
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
